To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
ArchiMed completes take-private deal of Natus for $1.1bn
As a result of the closing, Natus will no longer trade on the NASDAQ.
